• HSD45 Potential Patient Hub Services Opportunities in the Ex-US Drug Market: Borrowing from US Experience

    Jun 1, 2023, 00:00

  • HPR17 PDCI's Biopharmaceutical Ecosystem Index: Where Does Canada Rank on Its Attractiveness for New Medicine Launch?

    Jun 1, 2023, 00:00

  • MT22 Value Assessment of Prescription Digital Therapeutics

    Jun 1, 2023, 00:00

  • PCR90 Pilot Testing a Patient-Driven Discrete Choice Experiment Instrument for Patients with Chronic Obstructive Pulmonary Disease: Methods and Qualitative Results

    Jun 1, 2023, 00:00

  • EE366 Real-World Healthcare Resource Utilization and Cost By Relapse Frequency Among US Patients with Schizophrenia and Schizoaffective Disorder

    Jun 1, 2023, 00:00

  • EE353 Cost-Effectiveness of Ravidasvir Plus Sofosbuvir Compared to the Standard of Care in Patients with Chronic Hepatitis C in the Thai Healthcare Setting

    Jun 1, 2023, 00:00

  • PCR72 The Impact of Migraine on Canadians’ Productivity: A Real-World Pharmacy-Based Study

    Jun 1, 2023, 00:00

  • HTA74 HTA Processes for Medical Technologies across the World – Are All Hurdles the Same?

    Jun 1, 2023, 00:00

  • HPR76 Inequalities of the Infant Mortality and Poverty in Colombia: Analysis 1993 Vs 2019

    Jun 1, 2023, 00:00

  • HPR137 Interventions to Address Healthcare Disparities Among Cancer Patients and Survivors in the United States: A Scoping Review

    Jun 1, 2023, 00:00

  • EPH110 Structured Literature Review of Evidence on the Clinical, Humanistic, and Economic Burden of Primary Sclerosing Cholangitis

    Jun 1, 2023, 00:00

  • EE442 Direct Expenses Study of Liver Transplantation Treatment

    Jun 1, 2023, 00:00

  • EE512 Potential Long-Term Benefits of Extended Adjuvant Neratinib in Patients with High-Risk Hormone Receptor Positive (HR+) HER2+ Early-Stage Breast Cancer (ESBC) Following Use of T-DM1 or Pertuzumab: A Population Effectiveness Model

    Jun 1, 2023, 00:00

  • EE75 The Economic Value and Learning Curves Associated with Laser Vision Correction

    Jun 1, 2023, 00:00

  • HPR83 Coming to America: How Ex-US Drug Companies May Best Prepare for the Complexities of a US Market Product Launch

    Jun 1, 2023, 00:00

  • RWD111 Using a Centralized Platform to Integrate Retrospective and Prospective Data: Lessons Learned

    Jun 1, 2023, 00:00

  • HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System

    Jun 1, 2023, 00:00

  • MSR34 Is the Usage of Immature Survival Data Surviving the HTA Decision?

    Jun 1, 2023, 00:00

  • PCR123 Patient-Centric Care (PCC) in Higher-Risk Myelodysplastic Syndromes (HR-MDS): A Global Systematic Literature Review (SLR) and Gap Analysis

    Jun 1, 2023, 00:00

  • PCR113 Treatment Preferences Among Adults with Reduced Productivity Due to Depression

    Jun 1, 2023, 00:00

  • HTA105 Use of Real-World Evidence to Support Direct Oral Anti-Coagulant Reimbursement and Implementation in Atrial Fibrillation. a Comparison of Experiences in Three Markets

    Jun 1, 2023, 00:00

  • EE423 Impact of Inclusion of Finerenone in the Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Peru

    Jun 1, 2023, 00:00

  • MT53 Real World Patient Acceptance of Digital Therapeutics: A Review

    Jun 1, 2023, 00:00

  • PCR150 Effects of Smoking on the Prevalence of Self-Reported Antihypertensive Medication Use Among Community-Dwelling Stroke Survivors

    Jun 1, 2023, 00:00

  • CO183 The Use of NNT Modelling to Improve the Clinical Relevance of Economic Analyses

    Jun 1, 2023, 00:00

  • EPH218 Cardiac Manifestations Including Heart Failure and Myocardial Infarction Post COVID-19 Recovery: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • PCR162 Real-World Treatment Preferences Among People Living with ALS: A Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • CO168 Defining Clinically Meaningful Thresholds (CMT) for Forced Vital Capacity (FVC) and Six-Minute Walk Test (6MWT) in Patients with Late-Onset Pompe Disease (LOPD)

    Jun 1, 2023, 00:00

  • EE377 Cost-Effectiveness Analysis of Annual Routine Cognitive Assessment in People Living with HIV (PLWH) Aged 50 in the US

    Jun 1, 2023, 00:00

  • HPR79 Political Economy of NGO Contracting for TB Services through Govt Led Public Procurement System in Bangladesh

    Jun 1, 2023, 00:00

  • MSR18 Evaluating the Impact of Random Forest (RF) on Matching Adjusted Indirect Comparisons (MAICS) of Treatments between Trials: A Simulation Study

    Jun 1, 2023, 00:00

  • EPH194 Exploring the Association of Pain Severity and Perceived Health Status Among United States Adults Using 2019 Nationally Representative Data

    Jun 1, 2023, 00:00

  • EE20 Utilization, Reimbursements and Prices Trends of Hepatitis C Virus Drugs in the US Medicaid Programs from 2001 to 2021

    Jun 1, 2023, 00:00

  • PCR116 Off Episode Quality of Life Impact Scale (OFFELIA) in People with Parkinson’s Disease: New Evidence of Construct Validity

    Jun 1, 2023, 00:00

  • MSR26 External Validation of Parametric Survival Fitting of Mortality in Patients with Heart Failure

    Jun 1, 2023, 00:00

  • PCR104 How Do Chinese Draft Guidelines (2021) on Patient Focused Drug Development Compare with Those of EMA and FDA?

    Jun 1, 2023, 00:00

  • EPH214 The Effect of Exercise Habits on Reducing Medical Costs in Residents in a Japanese Rural Area

    Jun 1, 2023, 00:00

  • Perceived Importance of the Benefits and Harms of Colorectal Cancer Screening: A Best-Worst Scaling Study

    Jun 1, 2023, 00:00

  • CO214 Model Predictions for Lifetime Health Benefits of Mobocertinib and Current Treatment Options in Post-Platinum Patients with Locally Advanced or Metastatic NSCLC Harboring Egfr Exon 20 Insertion Mutation in China

    Jun 1, 2023, 00:00

  • OP8 Assessment of the PharmD Pharmacoeconomics Educational Environment in the United States

    Jun 1, 2023, 00:00

  • EE408 Direct Cost Analysis Associated with the Management of Patients with Metachromatic Leukodystrophy (MLD) across Nine European Countries

    Jun 1, 2023, 00:00

  • HTA35 Implications of EU HTA on Future Relevance of Real World Evidence in National Assessments

    Jun 1, 2023, 00:00

  • MSR39 Applying Machine Learning Techniques to Identify Undiagnosed Patients with Nonalcoholic Steatohepatitis (NASH)

    Jun 1, 2023, 00:00

  • P10 The Public's COVID-19 Fatigue and Mental Health Towards COVID-19 Public Health and Social Measures (PHSMS) and Mental Health in China: A Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • CO190 Clinical Outcomes of Semaglutide 2.4 Mg in Patients with Obesity or Overweight in a Real-World Setting: A 6-Month Retrospective Study in the United States

    Jun 1, 2023, 00:00

  • HPR55 Market Access Trends of Pharmaceutical Products in US, EU4 and UK (2016-2021)

    Jun 1, 2023, 00:00

  • EE465 Value Estimation of the Diabetes Prevention Program: How Well Does Clinical Trial-Based Cost-Effectiveness Apply to the Real World?

    Jun 1, 2023, 00:00

  • EE270 The Economic Burden of Metastatic Non-Small Cell Lung Cancer in US Patients without an EGFR or ALK Mutation

    Jun 1, 2023, 00:00

  • EE108 Estimating the Cost of End-of-Life Care Among US Adults: Real-World Evidence Using a Case-Crossover Study Design

    Jun 1, 2023, 00:00

  • MSR99 Machine Learning Models to Estimate Disease Activity Measures in Real-World Data Sources: Lessons Learned from Four Autoimmune Diseases

    Jun 1, 2023, 00:00

  • CO47 Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction: A Real-World Study

    Jun 1, 2023, 00:00

  • EE320 Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapies for Blood Cancers: A Systematic Review

    Jun 1, 2023, 00:00

  • MT9 European Clinical Attitudes and Experiences of a Thulium Fiber Laser System: A Cross-Sectional, Multi-National Survey

    Jun 1, 2023, 00:00

  • PCR84 The Urgency of Generating Real World Evidence Data to Bridge an Existing Gap between Randomized Clinical Trials and Clinical Practice in Rare and Orphan Kidney Diseases: An Ongoing Research from Main Available Platforms

    Jun 1, 2023, 00:00

  • RWD178 Real-World Treatment Patterns, Healthcare Resource Utilization (HRU) and Costs for Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL): Chimeric Antigen Receptor T-Cell (CAR T) and Monoclonal Antibodies (MAB) Therapies

    Jun 1, 2023, 00:00

  • HTA103 EU-HTA in 2025: Industry’S Stake in the Scoping Process

    Jun 1, 2023, 00:00

  • HSD114 "Value-Based Healthcare" Initiative Is like a Marathon, Not a Sprint: Achievements and Challenges in Brazil

    Jun 1, 2023, 00:00

  • PCR98 A Literature Review Assessing the Most Common Attributes Used in Stated-Preference Studies Assessing Influenza Vaccination: Do We Know What Health Care Professionals Value?

    Jun 1, 2023, 00:00

  • HSD71 Situational Diagnosis of the Health Rehabilitation Network - A Strategy to Improve Post-Stroke Care in the Brazilian Public Health System

    Jun 1, 2023, 00:00

  • MT14 Defining Health States to Assess the Cost-Effectiveness of Interventions in Laryngectomized Patients

    Jun 1, 2023, 00:00

  • PCR212 Correlation between Myasthenia Gravis Disease Severity and Impairment of Daily Living Activities of Real-World Patients in the United States and Five European Countries

    Jun 1, 2023, 00:00

  • RWD133 Clinical Trial Emulation of the Catt Using Data from the Iris® Registry (INTELLIGENT RESEARCH IN SIGHT) Using Exact Matching and Inverse Probability Weighting

    Jun 1, 2023, 00:00

  • PCR204 Real-World Evidence Collection in an Online Patient Community to Identify Lifestyle Challenges Considered Most Important to Patients with Chronic Pancreatitis

    Jun 1, 2023, 00:00

  • HSD28 Real-World Treatment Pathways Among Adult Patients with Myasthenia Gravis

    Jun 1, 2023, 00:00

  • EPH129 Comorbidity Patterns Among Older Women with Breast Cancer: A 10-Year Cohort Study Using an Unsupervised Machine Learning Approach

    Jun 1, 2023, 00:00

  • EE515 Impact of Accountable Care Organization (ACO) Enrollment on Health-Related Quality of Life (HRQOL) and Healthcare Costs Among Adult Patients with Cancer

    Jun 1, 2023, 00:00

  • EE225 The High Cost of Death after Acute Myocardial Infarctions: Results from a National US Hospital Database

    Jun 1, 2023, 00:00

  • EE56 Minimally Invasive Surfactant Treatment Versus Standard Therapy in Preterm Infants at Birth (OPTIMIST-A TRIAL): An Analysis of Initial Hospitalisation Costs and Resource Consumption

    Jun 1, 2023, 00:00

  • RWD41 Worsening Heart Failure Events after GDMT: What Contemporary Utilization of GDMT Among Patients with HFrEF Looks like in a U.S. Database

    Jun 1, 2023, 00:00

  • MSR71 Uniting Health Care Perspectives through Integration of Clinical and Claims Data: An Example of Bariatric Surgery Market

    Jun 1, 2023, 00:00

  • HPR16 Incorporating Added Therapeutic Benefit and Domestic Reference Pricing into Medicare Payment for Expensive Part B Drugs

    Jun 1, 2023, 00:00

  • HPR45 Analysis of Alternative Access Routes and Time to Access for Paediatric Indication Expansions with Consideration of Regulatory, Pricing, and Access Incentives

    Jun 1, 2023, 00:00

  • EPH118 Retrospective Analysis of Acute Complications in Burn Injury Patients with Vitiligo

    Jun 1, 2023, 00:00

  • CO104 Trajectories of Adherence to Pre-Exposure Prophylaxis (PrEP) and Risk of HIV Incidence

    Jun 1, 2023, 00:00

  • EE380 Cost-Effectiveness Analysis of Erlotinib Plus Bevacizumab As First-Line Therapy for Advanced EGFR Mutation-Positive Non-Squamous Non-Small Cell Lung Cancer in Japan

    Jun 1, 2023, 00:00

  • CO231 Some Considerations and Guidance for Analyzing Clinically Meaningful Change Using Anchor-Based Methods

    Jun 1, 2023, 00:00

  • PCR164 Adherence to Botulinumtoxin Treatment: A 2-Year Retrospective Claims Database Analysis

    Jun 1, 2023, 00:00

  • EE261 Cost-Effectiveness of Adding Darolutamide to Docetaxel and Androgen Deprivation Therapy in the Treatment of Metastatic Hormone-Sensitive Prostrate Cancer

    Jun 1, 2023, 00:00

  • RWD92 Prevalence and Factors Associated with the Use of Direct Oral Anticoagulants Andlow Molecular Weight Heparins (LMWH) in Cancer Patients

    Jun 1, 2023, 00:00

  • MT33 Evidence Trends in Remote Patient Monitoring and Remote Therapeutic Monitoring

    Jun 1, 2023, 00:00

  • Health-Related Quality of Life and Health State Utility Measurement

    Jun 1, 2023, 00:00

  • RWD51 Do the Characteristics of the Site of Care Influence Outcomes? Associations between Community Practice-Level Characteristics and Real-World Overall Survival Among Patients with Multiple Myeloma

    Jun 1, 2023, 00:00

  • HPR126 How Do the Reimbursement Opportunities for Digital Health Applications Vary across the US, Europe and Japan?

    Jun 1, 2023, 00:00

  • HTA63 The Data Lifecycle: Towards a Standardized Relational Data Model to Support Living Systematic Literature Reviews? – Use Case Demonstration with LiveSLR®

    Jun 1, 2023, 00:00

  • EE185 Budget Impact of Anti-Inflammatory Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Panama

    Jun 1, 2023, 00:00

  • EPH237 US Population at Elevated Risk for Cancer: Population Size and Characteristics

    Jun 1, 2023, 00:00

  • MSR59 Prediction of Cardiovascular Disease in Psoriasis Patients Using Machine Learning Models Trained on Nordic Real-World Data

    Jun 1, 2023, 00:00

  • PCR97 Comparison of Patient-Reported Outcomes and Conventional Clinical Measures in Hospital Quality Assessment for Knee Replacement Surgery

    Jun 1, 2023, 00:00

  • PCR233 Concept Elicitation Study to Characterize the Patient-Reported Experience of Gonorrhea Infection and Mapping of Concepts to Patient-Reported Outcome Measures

    Jun 1, 2023, 00:00

  • EE203 The Impact of Varying the Target Population on the Outcome of a Cost-Effectiveness Analysis: Hemophilia B As an Exemplary Disease

    Jun 1, 2023, 00:00

  • EE236 Healthcare Resource Utilization and Costs Associated with Acute COVID in Adult Patients Managed in the Community or Hospital Setting in England: A Population-Based Study

    Jun 1, 2023, 00:00

  • SA39 Targeted Literature Review of Economic Burden and Modelling Techniques for Duchenne Muscular Dystrophy

    Jun 1, 2023, 00:00

  • CO220 Real-World Effectiveness and Safety in a Phase 4 Study of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis

    Jun 1, 2023, 00:00

  • CO110 Hospitalizations, Clinical Characteristics and Mortality in Adults with Adrenomyeloneuropathy (AMN): A Retrospective Study

    Jun 1, 2023, 00:00

  • EE391 A Systematic Literature Review (SLR) of Economic Burden of Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Metastatic Breast Cancer (MBC) with at Least One Prior Therapy

    Jun 1, 2023, 00:00

  • CO19 Relative Efficacy of Pharmacological Treatments of Agitation and Aggression in Patients with Dementia: A Systematic Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • EE393 Ovarian Cancer Overview: Treatments and Costs in the Brazilian Outpatient Public Settings – A Claim Database (DATASUS) Study

    Jun 1, 2023, 00:00

  • Health Technology Assessment

    Jun 1, 2023, 00:00

  • SA61 Systematic Review of Japanese Literature – A Study to Assess the Benefit of Including Japanese-Language Searches and Japanese-Specific Databases

    Jun 1, 2023, 00:00

  • EE510 Economic Modeling of Adjuvant or Neoadjuvant Therapies in Oncology – HTA Review of NICE Technology Appraisals, 2019-2022

    Jun 1, 2023, 00:00

  • Mapping Oswestry Disability Index Responses to EQ-5D-3L Utility Values: Are Cost-Utility Results Valid?

    Jun 1, 2023, 00:00

  • Health Equity in HEOR

    Jun 1, 2023, 00:00

  • CO221 Efficacy and Safety of Personalized Topography-Guided-Lasik Laser Refractive Correction: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • EE267 Racial Disparity in Total Annual Healthcare Expenditure for Cervical Cancer Patients: A 6 Years (2014-2019) US National Study

    Jun 1, 2023, 00:00

  • EE413 The Cost of Accessing Abortion Services in Ghana: An Implication on Safe Abortion Uptake

    Jun 1, 2023, 00:00

  • MSR92 Racial and Smoking Status Disparities in Mediation Effects on Liraglutide-Associated Cardiovascular Outcomes: A Dynamic Path Analysis Using Leader Trial Data

    Jun 1, 2023, 00:00

  • HPR130 The Impact of Stay-at-Home Orders on Binge Drinking Patterns in the US

    Jun 1, 2023, 00:00

  • P40 How Did FDA Consider Patient Experience Data in Regulatory Decisions Among Approved Drugs in 2022?

    Jun 1, 2023, 00:00

  • EE132 Cost-Utility Analysis of Long-Acting Injectable (1-, 3-, AND 6-MONTH INJECTION) and Oral Paliperidone in Adults with Stable Schizophrenia

    Jun 1, 2023, 00:00

  • CO122 Late-Onset Pompe Disease (LOPD) Patients Treated with Avalglucosidase Alfa Show Favorable Results Compared to Cipaglucosidase Alfa Plus Miglustat: Indirect Treatment Comparison

    Jun 1, 2023, 00:00

  • CO23 Real-World Treatment Patterns and Survival with First-Line (1L) Pembrolizumab + Platinum + Taxane Therapy for Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the United States

    Jun 1, 2023, 00:00

  • EE249 Healthcare Resource Utilization with Adjunctive Cariprazine and Other Atypical Antipsychotics in Patients with Major Depressive Disorder

    Jun 1, 2023, 00:00

  • RWD123 Machine Learning (ML) Applied to Real-World Data to Guide Prescription of Immune-Therapies in Metastatic Melanoma: A Pilot Study

    Jun 1, 2023, 00:00

  • CO123 Health-Related Quality of Life (HRQOL) Among Mucopolysaccharidoses (MPS) Patients Receiving Enzyme Replacement Therapy (ERT): A Systematic Literature Review

    Jun 1, 2023, 00:00

  • PCR7 Association of Children's Type 1 Diabetes with Parents' Capability Well-Being Assessed By the ICECAP-A Measure

    Jun 1, 2023, 00:00

  • PCR50 The Development of a Valid Qualitative Standardized Interview Manual

    Jun 1, 2023, 00:00

  • RWD90 Impact of Relaxing Brain Metastases Exclusion Criteria on Colon Cancer Trials Population

    Jun 1, 2023, 00:00

  • EPH197 Using High Quality Open Data to Find Long Term Results in an Continuously Enrolled Population, an Example in BPH

    Jun 1, 2023, 00:00

  • HTA42 Summary of Recent Health Technology Assessments for New Cancer Pharmacological Technologies in the Brazilian Private Healthcare System

    Jun 1, 2023, 00:00

  • PCR4 A Targeted Literature Review of Disutilites for Type 2 Diabetes Treatment-Related Attributes

    Jun 1, 2023, 00:00

  • RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States

    Jun 1, 2023, 00:00

  • EE43 Health Care Resource Utilization (HCRU) and Costs of First-Line Systemic Therapy (1LT) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (a/mNSCLC) - A Secondary Analysis of Claims Data from the United States (US)

    Jun 1, 2023, 00:00

  • PCR234 Impact of Draining Tunnels on Patient- and Physician-Reported Burden in Patients with Hidradenitis Suppurativa (HS)

    Jun 1, 2023, 00:00

  • PCR87 Impact of Signs and Symptoms of Chronic Refractory Gout on Patient Health-Related Quality of Life

    Jun 1, 2023, 00:00

  • PCR81 The Economic Burden of Individuals Living with Generalized Myasthenia Gravis and Social Determinants of Health Barriers

    Jun 1, 2023, 00:00

  • OP12 Reconciling Standardisation Processes and Improvisation Practices in Health Care: How to Deal with Structural, Clinical and Performative Unpredictability

    Jun 1, 2023, 00:00

  • Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany [Editor's Choice]

    Jun 1, 2023, 00:00

  • EE502 Medical Expenditures Among Cancer Patients in the United States: Estimates from Medical Expenditure Panel Survey (MEPS) Data

    Jun 1, 2023, 00:00

  • PCR29 Sustained Humanistic Burden and Work Impact in Adults with Transfusion-Dependent Beta-Thalassemia (TDT): Results from a Global Longitudinal Survey

    Jun 1, 2023, 00:00

  • RWD15 Epidemiology Description, Treatment Patterns, Resource Utilization and Biomarker Testing of Metastatic Triple Negative Breast Cancer (TNBC) Patients in Costa Rica

    Jun 1, 2023, 00:00

  • OP21 The Pharmaceutical Industry's Carbon Footprint and Current Mitigation Strategies: A Literature Review

    Jun 1, 2023, 00:00

  • EE259 Burden of Essential Tremor: Associated Morbidities, Healthcare Resource Utilization and Costs in Medicare Beneficiaries on Drug Therapy

    Jun 1, 2023, 00:00

  • MSR21 Impact of Correlated Outcomes in Probabilistic Sensitivity Analyses When Treatment Effects Are Derived from a Network Meta-Analysis

    Jun 1, 2023, 00:00

  • HSD36 Economic Burden of Newly Diagnosed Patients with Plantar Fibromatosis (PF) in the United States (US)

    Jun 1, 2023, 00:00

  • EPH216 The Use of Pharmacological Treatment Management Vs. the Use of Diet Quality to Evaluate the Health Outcomes in Managing Type 2 Diabetes

    Jun 1, 2023, 00:00

  • CO93 A Qualitative Investigation of the Impact of the Sars-Cov-2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting

    Jun 1, 2023, 00:00

  • MSR77 Making a Case for Case Reports: A Scoping Review of the Use of and Challenges with Case Report Data in Quantitative Synthesis

    Jun 1, 2023, 00:00

  • EE257 Cost Effectiveness Analysis of Qulipta in Episodic Migraine Prophylaxis

    Jun 1, 2023, 00:00

  • Copyright/Subscription

    Jun 1, 2023, 00:00

  • PCR244 Validity of the EQ Health and Wellbeing Experimental Version (LONG AND SHORT) in the Italian Population

    Jun 1, 2023, 00:00

  • EE244 Cost-Effectiveness Analysis of Liposomal Amphotericin B Versus Isavuconazole for Treating Mucormycosis in the Consolidation Phase from the Perspective of the Brazilian Unified Health System

    Jun 1, 2023, 00:00

  • EE369 Soothing the Soul: Cost-Effectiveness Evaluation of Group Music Therapy in Reducing Clinically-Significant Agitation Among People with Dementia

    Jun 1, 2023, 00:00

  • HTA16 Eliciting Preferences for Health Technology Assessment Criteria Using Analytic Hierarchy Process and Discrete Choice Experiment in Kenya

    Jun 1, 2023, 00:00

  • HSD38 Operational Savings Generated in an Integrated Care Program for Patients with Complex Respiratory Diseases

    Jun 1, 2023, 00:00

  • HTA75 Prioritized Attributes to Better Define and Measure Innovation in Health Technology Assessment: Findings from an Expert Roundtable

    Jun 1, 2023, 00:00

  • SA5 Defining Colorectal Cancer Recurrence with Structured-Health Data Algorithms: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • RWD184 Performance of the National Library of Medicine Rxmix, FDA National Drug Code Directory, and Redbook to Identify Prescription Records

    Jun 1, 2023, 00:00

  • HTA69 Towards a Minimum Information Set Needed to Define Patient-Facing Digital Health Technology for Outcomes Research

    Jun 1, 2023, 00:00

  • EE211 Guidelines for the Economic Evaluation of Vaccination Programs in Canada

    Jun 1, 2023, 00:00

  • SA48 Do 30-Day Out-of-Pocket Costs Influence Rifaximin Treatment Retention in Patients with Hepatic Encephalopathy?

    Jun 1, 2023, 00:00

  • MT10 Clinical, Operational, and Economic Impacts of Automated Medication Dispensing Cabinets in Perioperative and Ambulatory Surgical Center Settings: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • PCR108 The Effect of Team Incentives on Medication Adheren Design of a Randomized Controlled Trial

    Jun 1, 2023, 00:00

  • PCR157 Sociopsychological Factors Related to Information Seeking during the COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • EE199 Cost-Effectiveness of Pembrolizumab for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Colombia

    Jun 1, 2023, 00:00

  • EPH141 Increased Risk of Anemia in Asthma Patients

    Jun 1, 2023, 00:00

  • RWD103 Comparative Effectiveness of a Bilayered Living Cellular Construct and a Cryopreserved Cadaveric Skin Allograft for Use in Venous Leg Ulcers

    Jun 1, 2023, 00:00

  • EE352 Diabetes Mellitus in Argentina: A Systematic Review for Constructing Its Economic Profile

    Jun 1, 2023, 00:00

  • MT40 Comparing Resource Consumption from an Economic Evaluation of Gore® Viatorr® Tips Endoprosthesis Versus Large Volume Paracentesis in the Spanish and U.K. Healthcare Systems

    Jun 1, 2023, 00:00

  • SA15 Clinical Outcomes of Pharmacological Therapies for Heart Failure in Black Vs. White Populations: A Meta-Analysis of Randomized Controlled Trials of Heart Failure Treatment

    Jun 1, 2023, 00:00

  • HPR38 Assessing the Usability of Insurance Payment Rate Data Under the Price Transparency Rules: A Case Study of Ohio Mental and Behavioral Health Services

    Jun 1, 2023, 00:00

  • RWD182 Influence of Multiple Instance Learning on the Generation of Computational Pathology Algorithms and Its Value-Based Impact

    Jun 1, 2023, 00:00

  • RWD104 Generalization of the Effectiveness of Baricitinib 4MG Among bDMARD-IR Rheumatoid Arthritis Patients from a RCT to a Real-World Population in China

    Jun 1, 2023, 00:00

  • EE426 A Comparison of the Cost-Saving Impact of Biosimilar Switching Policies across Canadian Provinces: A Case-Study for a Ranibizumab Biosimilar

    Jun 1, 2023, 00:00

  • EE396 Cost-Effectiveness of Gleolan Guided Surgery Compared to Conventional White Light Surgery for High Grade Glioma

    Jun 1, 2023, 00:00

  • EE212 Comprehensive Review of Methods to Estimate Market Share Uptakes in Budget Impact Models

    Jun 1, 2023, 00:00

  • HPR84 Pre-Approval Information Exchange (PIE). Are US Healthcare Decision Makers and Manufacturers Both Getting a Piece of the Pie?

    Jun 1, 2023, 00:00

  • HTA65 Societal and Governmental Perspective of Orphan Drugs - Is There an Impact on Value?

    Jun 1, 2023, 00:00

  • EE311 Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) Using the Standard of Care in Central America

    Jun 1, 2023, 00:00

  • SA35 Prognostic Factors and Effect Modifiers in Patients with Relapsed or Refractory Follicular Lymphoma Who Failed at Least 2 Lines of Therapy: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EE25 A Systematic Literature Review to Assess the Modeling Approaches in Economic Evaluations of Health Interventions for Adult Binge Eating Disorders

    Jun 1, 2023, 00:00

  • RWD179 Comparison of Influenza Vaccination Coverage Estimated from Administrative Claims and Electronic Health Records with Population-Based Survey Estimates, U.S., 2017-2018 Influenza Season

    Jun 1, 2023, 00:00

  • MSR88 Demonstrating the Generalizability of Claims Based Studies

    Jun 1, 2023, 00:00

  • CO102 Impact of Quality Improvement Support Program for Korean Long-Term Care Hospitals on Nursing Outcomes

    Jun 1, 2023, 00:00

  • EE450 Assessment of the Quality of Time-Driven Activity-Based Costing (TDABC) Studies on Cardiovascular Diseases and Oncology

    Jun 1, 2023, 00:00

  • RWD21 Immunoglobulin a Nephropathy Patient Reported Health Utility and Quality of Life: Evidence from Real-World Data

    Jun 1, 2023, 00:00

  • HTA96 Applying Early Health Technology Assessments to Inform Novel Health Technology Innovation

    Jun 1, 2023, 00:00

  • Grading Evidence to Support Legislative and Budget Proposals—Veterans Health Administration’s Key to Implementing the Evidence Act

    Jun 1, 2023, 00:00

  • EE318 Trends in Prices of New Oral Drugs for Chronic Use Approved By the FDA (1980-2021)

    Jun 1, 2023, 00:00

  • EE305 Cost Burden of Geographic Atrophy and Visual Impairment/Blindness in US Elderly Patients

    Jun 1, 2023, 00:00

  • EE130 Years of Potential Life Lost with Premature Mortality Caused By Injury in Mongolia

    Jun 1, 2023, 00:00

  • P51 Evaluating the Patient Experience with CD55 Deficiency with Hyperactivation of Complement, Angiopathic Thrombosis, and Protein-Losing Enteropathy (CHAPLE) Disease: A Deadly Ultra-Rare Pediatric Disease

    Jun 1, 2023, 00:00

  • HPR100 Trends in FDA Approvals of Cardiovascular Drugs and Medical Devices (1980-2021)

    Jun 1, 2023, 00:00

  • PCR191 A Review of the Influence of Stakeholder Preference Research on the EtR Framework

    Jun 1, 2023, 00:00

  • HTA83 Investigating the Net Benefit of a Clinical Algorithm Detecting Chemotherapy Patients’ Risk of Emergency Care and Inpatient Hospitalization

    Jun 1, 2023, 00:00

  • EPH75 Risk Factors Associated with Newly Diagnosed Attention-Deficit/Hyperactivity Disorder in Adults

    Jun 1, 2023, 00:00

  • EE402 Cost-Effectiveness Analysis of Pasireotide Long-Acting Release As a Second Line Treatment for Adult Acromegaly Patients

    Jun 1, 2023, 00:00

  • EE255 Healthcare Costs of Patients with Amyotrophic Lateral Sclerosis with Commercial or Medicare Insurance

    Jun 1, 2023, 00:00

  • CO132 Predictive Validity of Pt-Global Web-Tool/PG-SGA, and Impact of Malnutrition on Renal Outcomes in Chronic Kidney Disease Patients: A Hospital-Based Prospective Cohort

    Jun 1, 2023, 00:00

  • HSD98 Which Telehealth Features Matter Most? Ranking Results from HIV Care Providers and Patients Living with HIV in South Carolina

    Jun 1, 2023, 00:00

  • PCR71 Does Disease Impact Go Beyond the Healthcare System? Lessons from Generalized Myasthenia Gravis 360°

    Jun 1, 2023, 00:00

  • HSD65 From the Triple Aim to the Quintuple Aim to the ISPOR Value Flower: Are Health Systems Prepared for High-Value Cell and Gene Therapies?

    Jun 1, 2023, 00:00

  • RWD22 A Novel Patient-Centered Real-World Evidence Study Designed to Better Understand Chronic Inflammatory Demyelinating Polyneuropathy Using Longitudinal Data in the United States

    Jun 1, 2023, 00:00

  • HPR73 Time to Approval of Chimeric Antigen Receptor-T Cells (CAR-T) Therapies Among Nordic Countries

    Jun 1, 2023, 00:00

  • HPR40 Price Analysis of New Nervous System Drugs Marketed in the US (1980-2021)

    Jun 1, 2023, 00:00

  • MSR83 Predicting Pseudo Individual Patient-Level Data with Covariates

    Jun 1, 2023, 00:00

  • SA63 Identification of Patients Diagnosed with Rare and Emerging Diseases Utilizing the Trinetx Network: A Case Study of African and American Trypanosomiasis

    Jun 1, 2023, 00:00

  • PCR60 Oxford Participation and Activities Questionnaire (OX-PAQ): Tests of Data Quality, Score Reliability, Response Rate and Scaling Assumptions in People Aged 75 or over in Sweden

    Jun 1, 2023, 00:00

  • An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments

    Jun 1, 2023, 00:00

  • EE458 Economic Evaluation of Lifestyle Interventions to Promote Cognition in Older Adults with Chronic Stroke

    Jun 1, 2023, 00:00

  • EE370 Estimating the Direct Economic Burden of Osteoporotic Fractures in a Multinational Study: A Real-World Data Perspective

    Jun 1, 2023, 00:00

  • RWD35 Coding Trends of Single Gene and Next Generation Sequencing Tests for Patients with Advanced Non-Small Cell Lung Cancer Using a EHR-Linked Claims Database

    Jun 1, 2023, 00:00

  • EE545 Economic Burden in Patients with Hemophilia with Inhibitors: Results from a Real-World Cohort Study in the United States

    Jun 1, 2023, 00:00

  • CO153 Examining Time to All-Cause Hospitalization or Death Among Second-Generation Antipsychotics Long-Acting Injectables in Schizophrenia

    Jun 1, 2023, 00:00

  • RWD69 5-Year Graft Failure Outcomes Utilizing Kidneys with Higher Kidney Donor Profile Index Scores across Different Age Groups and Sex over a 10-Year Period

    Jun 1, 2023, 00:00

  • EE121 Marginal Health Care Expenditure of Patients with Viral Hepatitis in the US: Analysis of Medical Expenditure Panel Survey 2011-2020

    Jun 1, 2023, 00:00

  • EE466 Correcting a Cost-Effectiveness Analysis (CEA) with Suggestions on Ways of Avoiding Misinterpretations and Calculating Errors Associated with Them: The Singapore Diabetes Prevention (CEA)

    Jun 1, 2023, 00:00

  • HTA4 Pembrolizumab Vs. Standard of Care Chemotherapy As First-Line Treatment for Advanced Non-Small Cell Lung Cancer with High Pd-L1 Expression Levels: A Cost-Utility Analysis from the Ontario, Canada Public Payer Perspective

    Jun 1, 2023, 00:00

  • EPH47 Active Surveillance for Safety Monitoring of COVID-19 Vaccines in Saudi Arabia

    Jun 1, 2023, 00:00

  • EPH30 Burden of HPV-Associated Cancers Among Men in Ecuador, 2015-2019

    Jun 1, 2023, 00:00

  • P27 The Impact of Incorporating Survival Heterogeneity into Modeling of Survival Outcomes for Patients with Muscle-Invasive Bladder Cancer after Radical Resection: Analyses from a Retrospective Real-World Study in France

    Jun 1, 2023, 00:00

  • HTA70 Use of Economic Evaluation of Vaccines: The Experience in Colombia, 2000 to 2021

    Jun 1, 2023, 00:00

  • CO167 Evaluating Risk of Progression with Selumetinib in Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma: Propensity Score Method (PSM) Analysis of the Sprint Trial Vs a Natural History (NH) Control Arm

    Jun 1, 2023, 00:00

  • EPH201 Trends in Racial Disparities for Total Knee Arthroplasty — A US Hospital Database Analysis, 2000–2021

    Jun 1, 2023, 00:00

  • EPH209 Descriptive Analysis of High-Cost Claimants in a Multi-Employer Database

    Jun 1, 2023, 00:00

  • CO64 Efficacy and Safety of Exenatide for the Treatment of Parkinson’s Disease: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EE150 A Budget Impact Analysis of the Introduction of Mosunetuzumab for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US)

    Jun 1, 2023, 00:00

  • EE66 Estimating the Costs of Familial Hypercholesterolemia Management Using Primary Claims Data

    Jun 1, 2023, 00:00

  • CO177 The Burden of Spinal Muscular Atrophy Type 1 on Caregivers in Argentina: First Results of a Global Survey Launched in Latin America

    Jun 1, 2023, 00:00

  • HSD52 Closed Health Systems As Early Adopters and Incubators for Digital Behavioral Health Therapeutics

    Jun 1, 2023, 00:00

  • EE400 Economic Impact of Clinical Pharmacist Interventions in the Neonatal Intensive Care Unit in Qatar

    Jun 1, 2023, 00:00

  • CO33 Early Hemoglobin and Quality-of-Life Trends from OPERA: A Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria

    Jun 1, 2023, 00:00

  • CO97 Risk Factors, Presentation and Outcome in Acute Ischemic Stroke According to Social Position Indicators in Patients Hospitalized in a Referral Center in Bogotá 2011-2019

    Jun 1, 2023, 00:00

  • EE440 Trends in the Cost of Total Knee Arthroplasty — a US Hospital Database Analysis, 2000–2021

    Jun 1, 2023, 00:00

  • EE410 The Insurance Payer Perspective on Management Options for Early Pregnancy Loss in the United States

    Jun 1, 2023, 00:00

  • EE34 Cost-Effectiveness Analysis of Valbenazine Compared with Deutetrabenazine for the Management of Huntington Chorea

    Jun 1, 2023, 00:00

  • EE448 The Burden of Illness for Metastatic Synovial Sarcoma (MSS) and Myxoid Round Cell Liposarcoma (MMRCLS): A Seer-Medicare Analysis

    Jun 1, 2023, 00:00

  • HPR128 Use of Clinical Outcomes Assessments (COAS) By Hospitals in the USA, UK, France and Sweden: Multi-Stakeholder Viewpoints

    Jun 1, 2023, 00:00

  • EE371 Trends in the Economic Burden of Rheumatoid Arthritis in the US, 2008-2019

    Jun 1, 2023, 00:00

  • HPR4 $20.9 Billion Annually Wasted on “Defects in Value” for Total Knee and Hip Replacements in the United States

    Jun 1, 2023, 00:00

  • EE146 Cost-effectiveness of Tepotinib for Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Harboring Metex14 Skipping Alterations in Spain

    Jun 1, 2023, 00:00

  • PCR94 Uncovering Patient-Reported Outcome Differences between Undiagnosed and Diagnosed Individuals with Moderate to Severe Psoriasis

    Jun 1, 2023, 00:00

  • CO182 Developing Methods to Validate Outcome Measures Captured Via Wearable Activity Trackers

    Jun 1, 2023, 00:00

  • HPR118 Examining Non-Price Determinants of Regional Pharmaceutical Expenditures-a Case of Burkina Faso

    Jun 1, 2023, 00:00

  • RWD176 Use of the Narcotics Information Management System (NIMS) Data for Regulatory Scien Focusing on Methylphenidate Prescription

    Jun 1, 2023, 00:00

  • MSR15 Psychometric Validation of the Electronic Hidradenitis Suppurativa (HS) Symptom Daily Diary (eHSSDD) and Electronic HS Symptom Questionnaire (eHSSQ) Using Data from the Phase 3 BE HEARD Trials of Bimekizumab in HS

    Jun 1, 2023, 00:00

  • HSD29 Predictors of Neurokinin-Receptor Antagonist (NK1-RA) Overuse Among Women with Breast Cancer

    Jun 1, 2023, 00:00

  • EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom

    Jun 1, 2023, 00:00

  • CO69 Patient Journey of Triple Negative Breast Cancer in Five Healthcare Institutions from Colombia

    Jun 1, 2023, 00:00

  • RWD2 A Retrospective Cohort Study of Patients with Venous Thromboembolism (VTE): An Analysis from a Healthcare Maintenance Organization (HMO) Perspective in Brazil

    Jun 1, 2023, 00:00

  • EE209 Value Defects in Spine Surgery: How to Reduce Wasteful Care and Improve Value

    Jun 1, 2023, 00:00

  • EPH192 Association of Long COVID with Seeing Difficulties Among Adults in the United States

    Jun 1, 2023, 00:00

  • HSD63 Real-World Data Analysis of Genetic Testing for Inherited Retinal Diseases

    Jun 1, 2023, 00:00

  • SA37 Real-World Treatment Patterns (TxP) and Healthcare Resource Utilization (HRU) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) and Metastatic Hormone-SensitiveProstate Cancer (mHSPC) in China

    Jun 1, 2023, 00:00

  • CO121 Using Stated-Preferences Methods to Develop a Summary Metric to Determine Successful Treatment of Children with a Surgical Condition to Compare across Hospitals

    Jun 1, 2023, 00:00

  • EE125 Economic Evaluations of Pharmacological Treatments for Active Tuberculosis: A Systematic Review

    Jun 1, 2023, 00:00

  • HSD80 How Are We Treating Our Patients? An Experts’ Panel Perspective from Brazilian Healthcare System on Treatment Access for Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Jun 1, 2023, 00:00

  • EPH231 Cardiovascular Burden of Patients Diagnosed with Idiopathic Hypersomnia: Real-World Idiopathic Hypersomnia Total Health Model (CV-RHYTHM)

    Jun 1, 2023, 00:00

  • EE135 Cost Comparison of a Smartphone-Based Care Platform Versus Traditional Care in Total Knee Arthroplasty in the US: An Integrated Healthcare Delivery System Perspective

    Jun 1, 2023, 00:00

  • HTA20 Deconstructing ICER Value Assessments: Which Components Do Payers Value Most?

    Jun 1, 2023, 00:00

  • EPH68 Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder in West Virginia

    Jun 1, 2023, 00:00

  • EE245 Years of Potential Productive Life Lost Mortality Caused By Injury in Mongolia

    Jun 1, 2023, 00:00

  • EE281 Trends in Approvals and Price at Market Entry of New Drugs for Breast Cancer in the US (1980-2022)

    Jun 1, 2023, 00:00

  • RWD10 Risk of Depression before Alzheimer’s Disease Diagnosis and Hyperlipidemia Using Real-World Data

    Jun 1, 2023, 00:00

  • CO114 Real-World Experience Among Patients with Mantle Cell Lymphoma after Covalent Bruton Tyrosine Kinase Inhibitor Use in the United States: A Retrospective Electronic Health Record-Derived Study

    Jun 1, 2023, 00:00

  • RWD33 Cardiac Implantable Electronic Device Centers’ Landscape in the Brazilian Public Healthcare: A 12-Year Real World Data Analysis

    Jun 1, 2023, 00:00

  • EE485 Healthcare Utilization and Costs Decreased Over Time with Nusinersen Treatment in Patients with Spinal Muscular Atrophy

    Jun 1, 2023, 00:00

  • MSR82 A Methodological Framework to Conduct Data Sources Landscaping for Real-World Studies (RWS)

    Jun 1, 2023, 00:00

  • PCR63 A Time Trade-Off Study to Estimate Respiratory Syncytial Virus (RSV) Related Utility Values for Older Adults (OA) in the United States (US)

    Jun 1, 2023, 00:00

  • HSD101 The Key Role of Therapeutic Professionals in Rett Syndrome Care Pathway

    Jun 1, 2023, 00:00

  • SA59 Literature Review of Statistical Methods Comparisons through Simulations When Using External Control Arm for Regulatory or HTA Submissions

    Jun 1, 2023, 00:00

  • CO57 Real-World Differences between People Living with HIV Receiving B/FTC/TAF and Those Receiving Other Single Tablet Regimens (STR) in the United States

    Jun 1, 2023, 00:00

  • HSD26 Relationship between Sociodemographic Factors and Postpartum Depression Screening and Treatment

    Jun 1, 2023, 00:00

  • RWD46 Reclassification of COVID-19 Related ICD-10 Codes in Mexico: A Real-World Data Analysis of 1,937,360 Hospital Discharges from the Ministry of Health

    Jun 1, 2023, 00:00

  • EE472 US Cost-Effectiveness of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multi-Drug Resistant HIV

    Jun 1, 2023, 00:00

  • Health Service Delivery Process of Care

    Jun 1, 2023, 00:00

  • HPR24 Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured and after Transition to Medicare Advantage Versus Traditional Fee-for-Service

    Jun 1, 2023, 00:00

  • CO225 An Evaluation of the Design of Clinical Trials Conducted for Rheumatoid Arthritis, 2009-2022

    Jun 1, 2023, 00:00

  • EPH157 Environmental Pollution and Socioeconomic Status in Eastern China

    Jun 1, 2023, 00:00

  • EE72 A Value Pyramid to Guide Asthma Interventions in the UK

    Jun 1, 2023, 00:00

  • CO138 Comparative Effectiveness and Costs of Sacubitril/Valsartan Versus Angiotensin Receptor Blockers in Heart Failure with Preserved Ejection Fraction

    Jun 1, 2023, 00:00

  • HSD21 Telehealth: Interconnected Future of Healthcare in Emirate of Dubai, a Claims Data Analysis

    Jun 1, 2023, 00:00

  • EE100 Application of Real-World Data in Health Economic Evaluations in China: A Systematic Review

    Jun 1, 2023, 00:00

  • CO223 The Use of Artificial Intelligence to Guide Medication Dosage Is Associated with Improved Anemia Management and Lower Erythropoietin Stimulating Agents Consumption Among Dialysis Patients

    Jun 1, 2023, 00:00

  • EE337 Per-Member Per-Month Expenditure Value in Non-Oncology: A Targeted Review and Opinion

    Jun 1, 2023, 00:00

  • HTA55 Implications of EU HTA on Acceptance of Indirect Comparisons in National Assessments

    Jun 1, 2023, 00:00

  • EE109 Cost Effectiveness of Dual Vs. Triple Therapy in Management of Atrial Fibrillation with Percutaneous Coronary Intervention

    Jun 1, 2023, 00:00

  • CO120 Real-World Effectiveness of Monoclonal Antibodies for Patients with Multiple Myeloma: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

    Jun 1, 2023, 00:00

  • CO108 Longitudinal Trends in Hospitalization Rates in Patients with Later-Onset Spinal Muscular Atrophy (SMA) Treated with Nusinersen up to 4.5 Years: Results from the Cherish and Shine Studies

    Jun 1, 2023, 00:00

  • MSR13 Identification of Longitudinal Trajectories of Medication Non-Adherence and Their Time-Varying Predictors in Aging Patients in the United States

    Jun 1, 2023, 00:00

  • EE8 Cost-Effectiveness of Long-Term Medication Therapy for Obesity Management

    Jun 1, 2023, 00:00

  • EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia

    Jun 1, 2023, 00:00

  • CO196 Metformin Is Associated with Reduced Risk of Sepsis: Analysis of a U.S. Cohort from 2009-2019

    Jun 1, 2023, 00:00

  • EE145 Real-World Healthcare Resource Use, Costs, and Treatment Patterns in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with Different Epidermal Growth Factor Receptor Mutation Types

    Jun 1, 2023, 00:00

  • RWD141 AI-Powered Pre-Competitive Disease and Care Modeling: Building a Reference Disease-Centric Framework for Value-Based Decision Making

    Jun 1, 2023, 00:00

  • CO119 Clinical Utility of Circulating Tumor Cell Enumeration-Based Liquid Biopsy in Patients with Metastatic Breast Cancer: A Review of the Peer-Reviewed Clinical Literature

    Jun 1, 2023, 00:00

  • EPH245 Comparison of Intravitreal Fariciab and Aflibercept in the Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema: A Meta-Analysis and Systematic Review

    Jun 1, 2023, 00:00

  • EPH191 Identifying Geographic Disparities in Access to Psoriasis Care in Medicaid Patients

    Jun 1, 2023, 00:00

  • PCR73 Health-Related Quality of Life and Economic Burden in Chinese Patients with Cutaneous T-Cell Lymphoma (CTCL) – Results from Interim Analysis

    Jun 1, 2023, 00:00

  • EE218 The Wave of the Future? Alternative Digital Value Communication Solutions to Enhance Engagements between US Payers and MSLs

    Jun 1, 2023, 00:00

  • HPR139 Impact of Price Negotiation on the Pricing of Anticancer Drugs in China

    Jun 1, 2023, 00:00

  • HPR27 Socioeconomic Inequalities in out of Pocket and Catastrophic Health Expenditures Among the Households in Pakistan

    Jun 1, 2023, 00:00

  • PCR130 Beliefs Regarding Patient Experience in the Emergency Department Among Individuals Living with Sickle Cell Disease

    Jun 1, 2023, 00:00

  • EE420 Contamination Rate and Economic Evaluation for Repeated Use of Medicated Preservative-Free Unit-Dose Eye Drops

    Jun 1, 2023, 00:00

  • CO181 Clinical Characteristics of Patients with Sars-Cov-2 Omicron Variant and COVID-19 Vaccination with Clinical Outcome Findings in Shanghai, China: A Single Center, Retrospective, Observational Study

    Jun 1, 2023, 00:00

  • EE517 The Potential Effect of Future Medical Cost Changes on the Net Cost of Multi-Cancer Early Detection Testing

    Jun 1, 2023, 00:00

  • EE115 Nash Progression Rates Based on Fibrosis and Inflammation (NAS): A Paired Biopsy Analysis from a Natural History Cohort in the US

    Jun 1, 2023, 00:00

  • CO173 Quality of Life and Cost of Protraction or Orthognathic Surgery for Class III Malocclusion in Patients with Cleft Lip and Palate

    Jun 1, 2023, 00:00

  • EE527 A Systematic Literature Review of the Economic Burden of Leber Hereditary Optic Neuropathy (LHON)

    Jun 1, 2023, 00:00

  • EPH31 Incidence of Malignancies in Sickle Cell Disease: A Systematic Review

    Jun 1, 2023, 00:00

  • PCR83 Defining the Smallest Worthwhile Effect of Treatment for Progressive Nervous System Tumors in People with NF2-Related Schwannomatosis: Qualitative Patient Interview Results from a Multicenter Clinical Trial

    Jun 1, 2023, 00:00

  • RWD49 Burden of Hospitalizations in Amyotrophic Lateral Sclerosis (ALS): Comparison of Medicare and Private Payer Populations

    Jun 1, 2023, 00:00

  • EE390 Healthcare Resource Utilization (HCRU) and Costs in Patients with Metastatic Urothelial Cancer (MUC) Who Received First-Line (1L) Treatment: Results from Impact UC II

    Jun 1, 2023, 00:00

  • RWD3 Group-Based Trajectory Modeling to Evaluate Adherence Patterns for Direct Oral Anticoagulant Among Patients with Atrial Fibrillation

    Jun 1, 2023, 00:00

  • P2 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Transfusion-Dependent Beta-Thalassemia

    Jun 1, 2023, 00:00

  • HTA51 Impact of ICER Assessments on Payer Decision Making in the United States

    Jun 1, 2023, 00:00

  • HPR50 Exploring the Contribution of Health Gains and Cost-Offsets to Value-Based Drug Prices in Prior ICER Reviews

    Jun 1, 2023, 00:00

  • EPH170 Diagnoses of Long COVID in the United States: Analysis of a Large Claims Database

    Jun 1, 2023, 00:00

  • EE345 Strengths and Limitations of Different Costing Approaches Used for Hospital Budget Impact Models: Application to Imaging Guidance in Left Atrial Appendage Occlusion Procedures

    Jun 1, 2023, 00:00

  • MSR52 Identifying Adult Patients with Non-Relapsing Secondary Progressive Multiple Sclerosis Using Algorithms in US-Based Healthcare Databases

    Jun 1, 2023, 00:00

  • EPH148 Burden of Opioid Use Disorder on Hospitals in the United States

    Jun 1, 2023, 00:00

  • PCR54 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures (PROMS): Part II Psychometric Properties

    Jun 1, 2023, 00:00

  • PCR230 Estimating Utility Values Using the Duchenne Muscular Dystrophy-Quality of Life Measure (DMD-QOL): A New Preference-Based Measure for Duchenne Muscular Dystrophy

    Jun 1, 2023, 00:00

  • EE166 Cost-Effectiveness of Alpelisib Plus Fulvestrant in Postmenopausal Women with Hr+/HER2- Advanced Breast Cancer (ABC) in Qatar

    Jun 1, 2023, 00:00

  • EPH246 Real-World Evaluation of Health Disparities in Treatment Patterns for Systemic Lupus Erythematosus

    Jun 1, 2023, 00:00

  • EE542 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Guatemala

    Jun 1, 2023, 00:00

  • EPH130 Association of Lynch Syndrome with Skin Cancer: An Exploratory Analysis Using Claims Data

    Jun 1, 2023, 00:00

  • EPH16 Opioid-Related Overdose Deaths in the South Region of the U.S. from 2013 to 2020

    Jun 1, 2023, 00:00

  • HSD19 Comparing the Health Care Utilization of Those with Limited English Proficiency and Use of a Language Interpreter to Similar Individuals without Use of a Language Interpreter at Mayo Clinic

    Jun 1, 2023, 00:00

  • EE508 Cost of Liver Cancer Screening in Patients with Cirrhosis

    Jun 1, 2023, 00:00

  • EE387 Cost of Non-Melanoma Skin Cancer Care in the U.S.- An Analysis from Medicare Population

    Jun 1, 2023, 00:00

  • CO205 Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data

    Jun 1, 2023, 00:00

  • EE349 A Systematic Literature Review, Network Meta-Analysis, and Cost-Effectiveness Analysis of Resmetirom for the Treatment of Nonalcoholic Steatohepatitis

    Jun 1, 2023, 00:00

  • RWD125 An Exploratory Analysis of Real-World Data for Assessing Patient Characteristics, Region, Stage, and PD-L1 Health-Care Utilization Among U.S. Patients with Advanced Lung Cancer

    Jun 1, 2023, 00:00

  • PCR21 Patient-Reported Outcomes to Support Regulation, Reimbursement and Health Policy Among Patients with Head and Neck Cancers: A Systematic Review

    Jun 1, 2023, 00:00

  • EE453 Baseline Cognitive Performance Is a Determinant of Prospective Health Resource Utilization Among Adults with Chronic Stroke: A Secondary Analysis

    Jun 1, 2023, 00:00

  • HSD109 Diabetic Retinopathy Patients at Initiation of Anti-Vascular Endothelial Growth Factor Injection

    Jun 1, 2023, 00:00

  • RWD39 Who Is Using Data from the French Health Data Hub?

    Jun 1, 2023, 00:00

  • CO46 Determining Patient-Reported Outcomes Fit-for-Purpose By Cross-Linking Regulatory Perspective and Descriptive Information in Interconnected Databases

    Jun 1, 2023, 00:00

  • EE344 Cost-Effectiveness of a Novel Treatment for Stroke Prevention in Patients with Atrial Fibrillation: Results from an Early Economic Analysis

    Jun 1, 2023, 00:00

  • EPH176 What Macro-Level Social Determinants Are Associated with Mental Health Outcomes in Disability-Adjusted Life Year (DALY) for the Population Living in the Organisations for Economic Co-Operation and Development (OECD) Nations?

    Jun 1, 2023, 00:00

  • P12 Unsupervised Clustering and Binary Classification Analysis for Predicting COVID Syndrome (LONG COVID) in US Adults

    Jun 1, 2023, 00:00

  • HPR39 A Time-to-Event Framework for Quantifying Clinical Significance of Effect in Alzheimer’s Disease Clinical Trials

    Jun 1, 2023, 00:00

  • MT35 Prevalence of Medicare Beneficiaries Suitable for Transanal Irrigation Therapy Among Patients with Neurogenic Bowel Dysfunction

    Jun 1, 2023, 00:00

  • HTA3 Analysis of Canadian and International Health Technology Assessment Uncertainty for Spinal Muscular Atrophy Therapies

    Jun 1, 2023, 00:00

  • HSD49 Medication Use Among T2DM Patients Initiating Treatment with Once Weekly (OW) Semaglutide

    Jun 1, 2023, 00:00

  • EPH160 Racial/Ethnic Differences in the Use of Angiotensin II Receptor Stimulatory Vs. Inhibitory Antihypertensive Among US Adults with Hypertension

    Jun 1, 2023, 00:00

  • EPH189 Assessment of Burden of COVID-19 Infection and the Dynamics in African Union Member States

    Jun 1, 2023, 00:00

  • HPR132 Pricing Variations between Early Access Prices and List Prices in Switzerland

    Jun 1, 2023, 00:00

  • EPH185 Clinical, Humanistic, and Economic Benefits of Early Cancer Diagnosis: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • SA41 Evolving Payer Perception on Patient Centricity and Real-World Eviden Insights from a Quantitative Survey

    Jun 1, 2023, 00:00

  • RWD4 Developing a Risk Prediction Model for Heart Failure (HF) Incidence in Patients with Diabetes Mellitus Using AI Ml Techniques

    Jun 1, 2023, 00:00

  • PCR167 Patient Preferences for Lung Cancer Interception Therapy

    Jun 1, 2023, 00:00

  • EPH46 The Association between Vaccine Hesitancy and Pertussis: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • MSR4 Rasch Calibration of the 18-Item Multidimensional Health Locus of Control - Form B Scale

    Jun 1, 2023, 00:00

  • EE573 Cost-Effectiveness of Innovative Treatments of HER2+ Breast Cancer in Peru

    Jun 1, 2023, 00:00

  • Economic Considerations of Digital Health Technologies

    Jun 1, 2023, 00:00

  • P4 Cost–Effectiveness Analysis of Ivosidenib Versus Chemotherapy for Previously Treated IDH1–Mutant Advanced Intrahepatic Cholangiocarcinoma in Taiwan

    Jun 1, 2023, 00:00

  • PCR115 Adherence to Disease-Modifying Treatments in Patients with Active and Nonactive Progressive Multiple Sclerosis in the United States

    Jun 1, 2023, 00:00

  • EPH72 Prevalence of Fractures in People over 50 Years of Age with Osteoporosis in Colombia

    Jun 1, 2023, 00:00

  • CO65 Machine Learning-Based Explanation of Racial-Ethnic Disparities in 5-Year Cancer-Specific Survival Among Hormone Receptor-Positive Breast Cancer Patients in the United States

    Jun 1, 2023, 00:00

  • SA60 Technology and Device Acceptance Among an Older Population for Decentralized Clinical Trial Participation

    Jun 1, 2023, 00:00

  • EE3 Cost Estimation of Published Heart Failure and Edema Events in Hyperkalemic Patients on Patiromer and Sodium Zirconium Cyclosilicate

    Jun 1, 2023, 00:00

  • EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy

    Jun 1, 2023, 00:00

  • PCR203 The Clinical and Financial Impact of GLP-1 Receptor Agonist and SGLT-2 Inhibitor Use in Type 2 Diabetes Management of Blue Cross and Blue Shield of Louisiana Members

    Jun 1, 2023, 00:00

  • EPH108 Relationships between Zip Code Level Social Determinants of Health and Type 2 Diabetes Medication Adherence

    Jun 1, 2023, 00:00

  • RWD79 Relationship between Body Mass Index and Diagnosis of Overweight or Obesity in Veteran’s Administration Population

    Jun 1, 2023, 00:00

  • EE154 Budget Impact Analysis of Pembrolizumab Plus Enfortumab Vedotin As First-Line Treatment of Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma in USA

    Jun 1, 2023, 00:00

  • EPH66 Epidemiological Population Study of Sars-Cov-2 in Lake County, Illinois: Contact: Health-Related Quality of Life Assessment

    Jun 1, 2023, 00:00

  • HSD16 Impact of Provider Nudges on Herpes Zoster Vaccine Series Completion during the COVID-19 Pandemic in the United States

    Jun 1, 2023, 00:00

  • PCR114 Utilizing Time-Driven Activity Based Costing to Explore Variation in the Value of Hip Arthroscopy for Acetabular Labral Repair

    Jun 1, 2023, 00:00

  • EPH149 Risk Factors of Delayed Methotrexate Elimination after Receiving High-Dose Methotrexate Therapy

    Jun 1, 2023, 00:00

  • EPH59 Validating Claims-Based Identification of Patients with Overweight and Obesity Using a Linked Claims-Electronic Medical Record Database

    Jun 1, 2023, 00:00

  • CO171 Mental Health and Sleep Disorders in Pediatric Patients with and without Atopic Dermatitis

    Jun 1, 2023, 00:00

  • EE384 Cost-Effectiveness of Hemithyroidectomy Versus Total Thyroidectomy for Patients with Low Risk Differentiated Thyroid Cancer

    Jun 1, 2023, 00:00

  • RWD160 Race-Stratified Treatment Patterns Among Metastatic Hormone Sensitive Prostate Cancer Patients in US Community Oncology Practice Setting

    Jun 1, 2023, 00:00

  • EE193 Burden of Severe Infections in Primary Immunodeficiency (PI) Diseases

    Jun 1, 2023, 00:00

  • RWD153 Investigating Trends of Behavioral Healthcare Resource Utilization Burden in Children and Adolescents with Suicidal Symptoms in the United States: An Analysis of Electronic Health Record Data

    Jun 1, 2023, 00:00

  • CO66 Real-World Study on Characteristics, Post-Nephrectomy Journey, and Outcomes of Patients with Early-Stage Renal Cell Carcinoma Based on Risk Groups

    Jun 1, 2023, 00:00

  • EE309 The Economic Burden of B-Thalassaemia, Sickle Cell Disease, and Myelodysplastic Syndrome: A Literature Review

    Jun 1, 2023, 00:00

  • HPR7 Racialized Economic Segregation and Inequities in Survival Among Patients with Multiple Myeloma

    Jun 1, 2023, 00:00

  • HPR152 Continuous Wound Infiltration: A Post-Surgical Pain Relief Solution That Reduces Opioid Use but Causes Pain in the Patient’s Wallet Due to Lack of Insurance Reimbursement

    Jun 1, 2023, 00:00

  • EE498 Economic Evaluation of Nanoparticle Albumin-Bound paclitaxel for Previously Treated Advanced NSCLC in Japan

    Jun 1, 2023, 00:00

  • EPH164 Atrial Fibrillation Is Associated with Higher Incidence of Frailty in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study

    Jun 1, 2023, 00:00

  • EE354 Cost Benefit Associated with the Use of SITZMARKS® for the Diagnosis of Constipation in an Adult Population

    Jun 1, 2023, 00:00

  • HSD51 Differences in Disease Burden and Treatment Utilization By Socioeconomic Status Among a Large Cohort of Patients with COVID-19 Diagnosis in the United States

    Jun 1, 2023, 00:00

  • CO22 Tools for Assessing Therapeutic Progress in Patients with Rett Syndrome

    Jun 1, 2023, 00:00

  • Organizational Practices

    Jun 1, 2023, 00:00

  • HSD108 Adapting Evidence-Based Peri-Discharge Interventions for Reducing 30-Day Hospital Readmissions Among COPD Patients in Hong Kong: A Delphi Study Guided By the Grade Evidence-to-Decision Framework

    Jun 1, 2023, 00:00

  • EPH215 Yearly Trend of Obesity Prevalence Among Hospitalized Patients in the United States: 2017−2021

    Jun 1, 2023, 00:00

  • PCR210 Adaptive Choice Based Conjoint Contribution to the Elicitation of Patients’ Preferences and Shared Decision-Making Process for the Pharmaceutical Treatment for Osteoarthritis

    Jun 1, 2023, 00:00

  • PCR38 Contextualizing Health-State Utilities in Patients with Transfusion-Dependent eta-Thalassemia (TDT)

    Jun 1, 2023, 00:00

  • EE131 Post-Traumatic Stress Disorder (PTSD) in Caregivers: Review of the Existing Evidence and Proposed Framework to Estimate Economic Burden

    Jun 1, 2023, 00:00

  • EE346 Opportunity Cost of Not Preventing Heart Failure: Case Study of a Public Hospital in Ecuador

    Jun 1, 2023, 00:00

  • PCR75 Assessment of Completion Time to Optimize the Administration of Common Patient-Reported Outcome Measures (PROMS) in Oncology Clinical Trials

    Jun 1, 2023, 00:00

  • EPH169 Persons Diagnosed with COVID-19 in Linked Clinical Practice Research Datalink (CPRD) – Hospital Episode Statistics (HES) Data: A Cohort Description

    Jun 1, 2023, 00:00

  • HSD10 Efficiency of the Cervical Cancer Program on the Budget Execution Processes during COVID 19 Pandemic Years 2020 - 2021 in Peru

    Jun 1, 2023, 00:00

  • EPH155 Relative Effectiveness of Vaccination and Non-Pharmaceutical Interventions on COVID-19 Infection and Deaths in the US

    Jun 1, 2023, 00:00

  • HSD99 Telemedicine and the Utilization of Outpatient Mental Health Services By Patients with Incident Major Depressive Disorder during the COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • HPR41 Predictors of Epidermal Growth Factor (EGFR) Testing Among Patients with Metastatic Non-Small Cell Lung Cancer (MNSCLC) Treated in the Real-World Setting

    Jun 1, 2023, 00:00

  • MSR60 Merc: An R Package for Correcting Measurement Error Bias Based on Regression Calibration Method

    Jun 1, 2023, 00:00

  • EE143 Cost-Effectiveness of Ocrelizumab in First-Line Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in Chile

    Jun 1, 2023, 00:00

  • EE196 Impact of Inclusion of Finerenone in the Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Ecuador

    Jun 1, 2023, 00:00

  • RWD162 An Overview of Real-World Data Sources for Real-World Studies in Oncology and Rare Diseases in China

    Jun 1, 2023, 00:00

  • PCR151 Adherence to Direct Oral Anticoagulants and Incidence of Stroke/Acute Coronary Syndrome/Systemic Embolism Among Patients with Atrial Fibrillation Using a Marginal Structural Model

    Jun 1, 2023, 00:00

  • HPR44 Evolving PICO Characteristics in the Early Oncology Treatment Lifecycle: Differences from Trials to Treatment Guidelines

    Jun 1, 2023, 00:00

  • EE518 Characteristics of the Clinical Pharmacist Interventions at a Tertiary Cancer Care Hospital in Qatar

    Jun 1, 2023, 00:00

  • MSR37 Identifying Clinical Subtypes of Long COVID: An Unsupervised Machine Learning Approach

    Jun 1, 2023, 00:00

  • P38 Current Practices and Challenges When Submitting Patient Experience Data for US Regulatory Decision-Making: An Industry Survey

    Jun 1, 2023, 00:00

  • EE273 Cost-Effectiveness Analysis of First Line Treatment Strategies for Acute Promyelocytic Leukemia in Adults in Colombia

    Jun 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19 (current)
  • 20
  • »